Genetic data reveal link between Lp(a) level, atrial fibrillation risk

Lipoprotein(a) may have a causal role in incident atrial fibrillation risk, independent of its effect on atherosclerotic CVD, according to an analysis of U.K. Biobank data.
“Lipoprotein(a) is associated with an increased risk for atrial fibrillation and this appears to be a causal relationship independent of coronary artery disease and aortic valve stenosis,” Guillaume Pare, MD, MSc, FRCPC, professor of pathology and molecular medicine and the Canada Research Chair in genetic and molecular epidemiology at McMaster University Population Health Research Institute and the David Braley

Lipoprotein(a) may have a causal role in incident atrial fibrillation risk, independent of its effect on atherosclerotic CVD, according to an analysis of U.K. Biobank data.
“Lipoprotein(a) is associated with an increased risk for atrial fibrillation and this appears to be a causal relationship independent of coronary artery disease and aortic valve stenosis,” Guillaume Pare, MD, MSc, FRCPC, professor of pathology and molecular medicine and the Canada Research Chair in genetic and molecular epidemiology at McMaster University Population Health Research Institute and the David Braley